ArticleFrontiers in psychiatry2025
Case Report: Scurvy-a modifiable cause of psychiatric refractoriness and lithium pharmacokinetic abnormalities in autism.
Article in Frontiers in psychiatry, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Scurvy, although rare in developed countries, can notably occur in individuals with extreme dietary selectivity, particularly those with neurodevelopmental disorders. We describe the case of an 18-year-old woman with autism spectrum disorder and severe intellectual disability who presented with severe behavioral dysregulation and limited response to multiple psychotropic regimens. Despite progressive lithium dose escalation, serum levels remained subtherapeutic. The turning point came with the diagnosis of profound vitamin C deficiency (ascorbic acid <1 µmol/L), prompting high-dose supplementation. Within days, the patient showed rapid behavioral improvement and a marked rise in serum lithium concentrations, necessitating dose reduction. First, nutritional deficiencies-particularly scurvy-can manifest primarily through psychiatric and behavioral symptoms in vulnerable populations, often resulting in misdiagnosis and polypharmacy. Second, although still speculative, we hypothesize that vitamin C status may affect lithium pharmacokinetics. This case underscores the importance of nutritional screening in refractory psychiatric presentations, particularly in individuals with restrictive diets, and highlights a potentially underrecognized interaction between vitamin C and lithium that warrants further investigation.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.